Environmental and biological monitoring of endocrine disrupting chemicals

Chemosphere

Volumn 39, Issue 8, 1999, Pages 1301-1307

  Menditto, A ^a   Turrio Baldassarri, L ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMARKERS; EPIDEMIOLOGY; RISK ASSESSMENT; TOXICITY;

ENDOCRINE DISRUPTING COMPOUNDS (EDC);

TOXIC MATERIALS;

ENVIRONMENTAL CHEMICAL;

BIOLOGICAL MONITORING; CONFERENCE PAPER; COOPERATION; ENDOCRINE DISEASE; ENVIRONMENTAL MONITORING; GENITAL SYSTEM; HUMAN; PRACTICE GUIDELINE;

EID: 0033214384     PISSN: 00456535     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0045-6535(99)00198-8     Document Type: Conference Paper

References (36)

1. R. Visser, Ativities of the OECD in the field of chemical control with particular reference to the work on high production volume chemicals, Ann. 1st. Super. Sanità 30, 373-381 (1994).
2. WHO. Biomarkers and risk assessment: Concepts and principles. Environmental Health Criteria 155, IPCS, World Health Organization, Geneva (1993).
3. J.R. Kavlock, G.P. Daston, C. DeRosa, P. Fenner-Crisp, L.E. Gray, S. Kaattari, G. Lucier, M. Luster, M.J. Mac, C. Maczka, R. Miller, J. Moore, R. Rolland, G. Scott, M. Sheehan, T. Sink and H.A. Tilson, Research needs for the risk assessment of health and environmental effects of endocrine disruptors: A report of the U.S. Sponsored workshop, Environ. Health Perspect. 104, (suppl. 4), 715-740 (1996).
4. EC. Report on Proceedings. European Workshop on the Impact of Endocrine Disruptors on Human Health and Wildlife. European Commission, DG XII, Environment and Climate Research Programme. EUR 17549, December 2-4 (Weybridge, UK) (1996).
5. A. O. Check and J.A. McLachlan. Environmental hormones and the male reproductive system, J. Androl. 19, 5-10 (1998).
6. P. Boyle, S. B. Kaye, A. G. Robertson. Changes in testicular cancer in Scotland, Eur. J. Cancer Clin. Oncol. 23, 827-830 (1987).
7. A. Giwercman, E. Carlsen, N. Keiding, N.E. Skakkebaek. Evidence for increasing incidence of abnormalities of the human testis: A review, Environ. Health Perspect. 101 (Suppl 2), 65-71 (1993).
8. H-O. Adami, R. Bergstrom, M. Mohner, W. Zatonski, H. Storm, A. Ekbom, S. Tretli, L. Teppo, H. Ziegler, M. Rahu, R. Gurevicius, A. Stengrevics, Testicular cancer in nine northern european countries, Int. J. Cancer 59, 33-38 (1994).
9. E. Carlsen, A. Giwercman, N. Keiding, N. E. Skakkebaek, Evidence for decreasing quality of semen during past 50 years, BMJ 305, 609-613 (1992).
10. J. Auger, J.M. Kunstmann, F. Czyglik, P. Jouannet, Decline in semen quality among fertile men in paris during the past 20 years, N. Engl. J. Med. 332, 281-285 (1995).
11. J. Ginsburs, S. Okolo, G. Prelevic and P. Hardiman, Residence in the London area and sperm density, Lancet, 343, 230 (1994).
12. S.H. Swan, E.P. Elkin and L Fenster, Have sperm densities declined? A reanalysis of global trend data, Environ. Healt Perspect. 105, 1228-1232 (1997).
13. H. Fish , E. Gubuloff, J.H. Olson, J. Feldshuh, S.J. Broder and D.H. Barad, Semen analyses in 1283 men from the United States over a 25-year period: No decline in quality, Fertil Steril 65, 1009-1014 (1996).
14. H. Fish and E.T. Gubuloff, Geographic variations in sperm counts: A potential cause of bias in studies of semen quality, Fertil Steril 65, 1044-1046 (1996).
15. J. Toppari, J.C. Larsen, P. Christiansen, A. Giwercman, P. Grandjean, L.J. Guillette, B Jegou, T.K. Jensen, P. Jouannet, N. Keiding, H Leffers, J.A. McLachlan, O. Meyer, M. Iler, E.R.D. Meyts, T. Acheike, R. Sharpe, J. Sumpter and N.E. Skakkebaek, Male reproductive health and environmental xenoestrogens, Environ. Health Perspect. 104 (suppl. 4), 741-803 (1996).
16. P. Mocarelli, P. Brambilla, P.M. Geryhoux, D.G. Patterson and L.L. Needham, Change in sex ratio with exposure to dioxin, Lancet 348, 409 (1996).
17. H. Moller, Change in male: Female ratio among newborn infants in Denmark, Lancet 348, 828-829 (1996).
18. R.M. Sharp and N.E. Skaekkebaek, Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet 341, 1392-1395 (1993).
19. S.G. Driscoll and S.H. Taylor, Effects of prenatal estrogen on the male urogenital system, Obstet. Gynecol. 56, 537-542 (1980).
20. A.L. Herbst, H. Ulfelder and D.C. Poskanzer, Adenocarcinoma of the vagina. Association of maternal diethylstilbestrol theraphy with tumor appearance in young woman, N. Engl. J. Med. 261, 641-644 (1959).
21. OECD. Draft Detailed Review Paper: Appraisal of Test Methods for Sex-Hormone Disrupting Chemicals. OECD Environmental Health and Safety Publications. Paris (1997).
22. G.A. Aresini, The role of biomarkers in the EC directives on health and safety, Toxicol. Lett. 77, 191-194 (1995).
23. T. Colborn, F.S. vom Saal, A.M. Soto, Developmental effects of endocrine-disrupting chemicals in wildlife and humans, Environ. Health Perspect. 101, 378-384 (1993).
24. L. Needham, D. Patterson, J. Pirkle, E. Sampson and R. Jackson, Endocrine disrupting studies at the national center for environmental health: Laboratory perspectives, Organohalogen Compounds, R. Hites editor, Bloomington, Vol. 33, 420-425 (1997).
25. D.E. Schulz, G. Petrick and J.C. Duinker, Complete characterization of polychlorinated biphenyl congeners in commercial aroclor and clophen mixtures by multidimensional gas cromatography-electron capture detection, Environ. Sci. Technol. 23, 852-859 (1989).
26. L. Turrio Baldassarri, A. di Domenico, A. Fulgenzi, N. Iacovella and C. La Rocca: Levels of polychlorobiphenyl congeners in mean diet samples from different Italian areas. In: Organohalogen Compounds - Dioxin '98, Vol. 38, pp. 195-198, August 16-22, Stockholm, Sweden (1998).
27. J.M. Bergeron, D. Crews, J.A. McLachlan, PCBs as environmental estrogens: Turtle sex determination as a biomarker of environmental contamination. Environ. Health Perspect. 102, 780-781 (1994).
28. E. Klasson Wehler, L. Hovander, A. Bergman, New organohalogen in human plasma - Identification and quantification, Organohalogen Compounds, R. Hites Ed., Bloomington, Vol. 33, 420-425 (1997).
29. J. de Boer, Toxaphene - Recent developments in analysis and biomonitoring, Organohalogen Compounds. R. Hites Ed., Bloomington, Vol. 33, 420-425 (1997).
30. B.G.J. Heinzow and A. McLean, Critical evaluation of current concepts in exposure assessment. Clin. Chem. 40, 1368-1375 (1994).
31. P. Grandjean, Biomarkers in epidemiology. Clin. Chem. 41, 1800-1803 (1995).
32. A.M. Soto, C. Sonnenschein, K.L. Chung, M.F. Fernandez, N. Olea and F. Olea Serrano, The E-SCREEN assay as a tool to identify estrogens: An update on estrogenic environmental pollutants. Environ. Health Perspect. 103 (Suppl. 7), 113-122 (1995).
33. C. Sonnenschein, A. M. Soto, M.F. Fernandez, N. Olea, F. Olea-Serrano and M.D. Ruiz-Lopez, Development of a marker of estrogenic exposure in human serum, Clin. Chem. 41, 1888-1895 (1995).
34. A.M. Soto, M.F. Fernandez, M.F. Luizzi, A.S. Oles Karasko and C. Sonnenschein, Developing a marker of exposure to xenoestrogen mixtures in human serum, Environ. Health Perspect. 105 (Suppl. 3), 647-654 (1997).
35. S.A. Heppel, N.D. Denslow, L.C. Folmar and C.V. Sullivan, Universal assay of vitellogenin as a biomarker for environmental estrogens, Environ. Health Perspect., 103 (suppl. 7), 9-15 (1995).
36. J.C. Cook, A. M. Kaplan, L.G. Davis and C. O'Connor, Development of a tier I screening battery for detecting endocrine-active compounds (eacs), Regul. Toxicol. Pharmacol. 26, 60-68 (1997).